Evaluating antimalarial safety

Event 1 Jan 2014



  • Ms Elizabeth Allen, University of Cape Town, South Africa
  • Ms Cheryl Pace, Liverpool School of Tropical Medicine, UK
  • Dr Lasse Vestergaard, WHO Western Pacific Region, Philippines

Malaria programme managers and global health colleagues are welcome to join the webinar.

Discussion points will include:

  • What does ACT Consortium research tell us about antimalarial safety?
    Can approaches for recording participant-reported harms in malaria clinical drug trials be harmonised?
  • How would you use a centralised safety repository for assessing harms? 
  • How does our novel data collection tool facilitate harms data capture by non-clinicians?
  • What do we know of the interactions between malaria and HIV drugs in malaria endemic areas?